CSO Hamid Khoja Buys $0.5M in FibroBiologics Private Placement at $1.675/Share
FBLG has more than doubled off its 52-week low of $0.62.
Summary
FibroBiologics CSO Hamid Khoja bought $0.5M of stock and warrants in a private placement at $1.675 per share, raising his stake to 7.5% of the company.
Key Events · Ownership and Investor Activity · FBLG
-
CSO Invests $0.5M in Private Placement
Hamid Khoja, Chief Scientific Officer, acquired 298,508 shares plus warrants for 298,508 shares at $1.675 per share/unit, closing September 15, 2026, for gross proceeds of approximately $0.5 million.
-
Warrant Terms
Warrants are exercisable at $1.55 per share, expire in five years, and carry standard anti-dilution adjustments for stock splits, dividends, rights offerings, and pro rata distributions.
-
Ownership Rises to 7.5%
Khoja now beneficially owns 630,009 shares (7.5% of outstanding common stock), comprising 301,571 shares, 298,508 warrant shares, and 29,930 vested option shares.
-
Distressed Backdrop
The investment follows a Nasdaq delisting determination (July 22, 2026), a going-concern warning, and a material weakness disclosed in the Q2 2026 10-Q, plus multiple dilutive financings in June-July 2026.
Analysis · FBLG · Life Sciences
Chief Scientific Officer Hamid Khoja invested approximately $0.5 million in a private placement that closed September 15, 2026, acquiring 298,508 shares plus warrants to purchase an equal number of shares at $1.55. The purchase price of $1.675 per share/unit is above the current market price of $1.485, and the deal comes amid a going-concern warning, a Nasdaq delisting determination, and a series of dilutive financings disclosed in recent filings. An insider putting personal funds into the company at this stage is a meaningful vote of confidence, though the warrants add future dilution risk.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.5% of the 1699 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FBLG was trading at $1.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $0.62 to $12.40. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.